[1]安 洁,信栓力,刘吉祥,等.盲肌样蛋白1(MBNL1)对血小板衍生生长因子诱导大鼠血管平滑肌细胞表型转换的作用研究[J].医学信息,2022,35(01):79-83.[doi:10.3969/j.issn.1006-1959.2022.01.019]
 AN Jie,XIN Shuan-li,LIU Ji-xiang,et al.Effect of Muscleblind-like 1 (MBNL1) on Phenotypic Switching of Rat Vascular Smooth Muscle Cells Induced by Platelet Derived Growth Factor[J].Medical Information,2022,35(01):79-83.[doi:10.3969/j.issn.1006-1959.2022.01.019]
点击复制

盲肌样蛋白1(MBNL1)对血小板衍生生长因子诱导大鼠血管平滑肌细胞表型转换的作用研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年01期
页码:
79-83
栏目:
论著
出版日期:
2022-01-01

文章信息/Info

Title:
Effect of Muscleblind-like 1 (MBNL1) on Phenotypic Switching of Rat Vascular Smooth Muscle Cells Induced by Platelet Derived Growth Factor
文章编号:
1006-1959(2022)01-0079-05
作者:
安 洁信栓力刘吉祥
(邯郸市第一医院心内一科1,神外一科2,河北 邯郸 056002)
Author(s):
AN JieXIN Shuan-liLIU Ji-xianget al.
(The First Department of Cardiology1,the First Department of Neurosurgery2,Handan First Hospital,Handan 056002,Hebei,China)
关键词:
血管平滑肌细胞表型转换盲肌样蛋白1
Keywords:
Vascular smooth muscle cellsPhenotypic transformationMuscleblind-like 1
分类号:
R54
DOI:
10.3969/j.issn.1006-1959.2022.01.019
文献标志码:
A
摘要:
目的 对盲肌样蛋白1(MBNL1)在血管平滑肌细胞(VSMCs)表型转换中的作用进行研究。方法 分离并鉴定大鼠血管平滑肌细胞,分组为对照组、10 ng/ml组、20 ng/ml组、40 ng/ml组、80 ng/ml组,给予不同浓度血小板衍生生长因子(PDGF-bb),通过Western blot检测各组MBNL1表达水平改变情况。使用慢病毒在细胞水平过表达MBNL1,分为Lv-nc组、Lv-nc+PDGF-bb组、Lv-mbnl1组、Lv-mbnl1+PDGF-bb组,并给予PDGF-bb刺激。使用siRNA在细胞水平敲低MBNL1,分为siRNA-nc组、siRNA-nc+PDGF-bb组、siRNA-mbnl1组、siRNA-mbnl1+PDGF-bb组,并给予PDGF-bb刺激,通过Transwell实验检测细胞迁移能力。结果 给予PDGF-bb后10 ng/ml组、20 ng/ml组、40 ng/ml组、80 ng/ml组MBNL1表达量较对照组增高(P<0.05); Lv-nc组细胞迁移数与Lv-mbnl1组比较,差异无统计学意义(P>0.05);Lv-nc+PDGF-bb组细胞迁移数较Lv-mbnl1组高(P<0.05);siRNA-nc组细胞迁移数与siRNA-mbnl1组比较,差异有统计学意义(P<0.05);siRNA-nc+PDGF-bb组细胞迁移数低于siRNA-mbnl1组(P<0.05)。结论 MBNL1抑制VSMCs迁移能力进而影响细胞表型转换。
Abstract:
Objective To investigate the role of muscleblind-like 1 (MBNL1) in phenotypic switching of vascular smooth muscle cells (VSMCs).Methods Rat vascular smooth muscle cells were isolated and identified, and divided into control group, 10 ng/ml group, 20 ng/ml group, 40 ng/ml group, and 80 ng/ml group. Different concentrations of platelet-derived growth factor (PDGF-bb) were given, and the change of MBNL1 expression level in each group was detected by Western blot. The lentivirus was used to overexpress MBNL1 at the cell level, which was divided into Lv-nc group, Lv-nc+PDGF-bb group, Lv-mbnl1 group and Lv-mbnl1+PDGF-bb group, and PDGF-bb stimulation was given. The MBNL1 was knocked down by siRNA at the cell level, which was divided into siRNA-nc group, siRNA-nc+PDGF-bb group, siRNA-mbnl1 group, and siRNA-mbnl1+PDGF-bb group. PDGF-bb stimulation was given, and the cell migration ability was detected by Transwell experiment.Results The expression levels of MBNL1 in the 10 ng/ml group, 20 ng/ml group, 40 ng/ml group and 80 ng/ml group after PDGF-bb administration were higher than those in the control group (P<0.05). There was no significant difference in cell migration between Lv-nc group and Lv-mbnl1 group (P>0.05). The number of cell migration in Lv-nc+PDGF-bb group was higher than that in Lv-mbnl1 group (P<0.05). The number of cell migration in siRNA-nc group was significantly different from that in siRNA-mbnl1 group (P<0.05). The number of cell migration in siRNA-nc+PDGF-bb group was lower than that in siRNA-mbnl1 group (P<0.05).Conclusion MBNL1 inhibits the migration ability of VSMCs and further affects cell phenotype conversion.

参考文献/References:

[1]Rensen SS,Doevendans PA,van Eys GJ.Regulation and characteristics of vascular smooth muscle cell phenotypic diversity[J].Neth Heart J,2007,15(3):100-108.[2]Frismantiene A,Philippova M,Erne P,et al.Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J].Cell Signal,2018(52):48-64.[3]Taylor K,Sznajder LJ,Cywoniuk P,et al.MBNL splicing activity depends on RNA binding site structural context[J].Nucleic Acids Res,2018,46(17):9119-9133.[4]Konieczny P,Stepniak-Konieczna E,Sobczak K.MBNL expression in autoregulatory feedback loops[J].RNA Biol,2018,15(1):1-8.[5]Song KY,Guo XM,Wang HQ,et al.MBNL1 reverses the proliferation defect of skeletal muscle satellite cells in myotonic dystrophy type 1 by inhibiting autophagy via the mTOR pathway[J].Cell Death Dis,2020,11(7):545.[6]López-Martínez A,Soblechero-Martín P,de-la-Puente-Ovejero L,et al.An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I[J].Genes (Basel),2020,11(9):1109.[7]Poulin H,Mercier A,Djemai M,et al.iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities[J].Sci Rep,2021,11(1):2500.[8]Xu Y,Liang C,Luo Y,et al.MBNL1 regulates isoproterenol-induced myocardial remodelling in vitro and in vivo[J].J Cell Mol Med,2021,25(2):1100-1115.[9]Huan W,Zhang J,Li Y,et al.Involvement of DHX9/YB-1 complex induced alternative splicing of Krüppel-like factor 5 mRNA in phenotypic transformation of vascular smooth muscle cells[J].Am J Physiol Cell Physiol,2019,317(2):C262-C269.[10]Pullmann R Jr,Juhaszova M,López de Silanes I,et al.Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR[J].J Biol Chem,2005,280(24):22819-22826.[11]Caines R,Cochrane A,Kelaini S,et al.The RNA-binding protein QKI controls alternative splicing in vascular cells,producing an effective model for therapy[J].J Cell Sci,2019,132(16):jcs230276.[12]Wan XJ,Zhao HC,Zhang P,et al.Involvement of BK channel in differentiation of vascular smooth muscle cells induced by mechanical stretch[J].Int J Biochem Cell Biol,2015(59):21-29.[13]Davis J,Salomonis N,Ghearing N,et al.MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response[J].Nat Commun,2015(6):10084.[14]Nagao M,Lyu Q,Zhao Q,et al.Coronary Disease-Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway[J].Circ Res,2020,126(4):517-529.[15]Lacolley P,Li Z,Challande P,et al.SRF/myocardin: a novel molecular axis regulating vascular smooth muscle cell stiffening in hypertension[J].Cardiovasc Res,2017,113(2):120-122.[16]Woo CC,Liu W,Lin XY,et al.The interaction between 30b-5p miRNA and MBNL1 mRNA is involved in vascular smooth muscle cell differentiation in patients with coronary atherosclerosis[J].Int J Mol Sci,2019,21(1):11.[17]Li Y,Guo X,Xue G,et al.RNA Splicing of the Abi1 Gene by MBNL1 contributes to macrophage-like phenotype modulation of vascular smooth muscle cell during atherogenesis[J].Cell Prolif,2021,54(5):e13023.[18]Chen J,Wang J,Qian J,et al.MBNL1 Suppressed Cancer Metastatic of Skin Squamous Cell Carcinoma Via by TIAL1/MYOD1/Caspase-9/3 Signaling Pathways[J].Technol Cancer Res Treat,2021:1533033820960755.[19]Afewerki T,Ahmed S,Warren D.Emerging regulators of vascular smooth muscle cell migration[J].J Muscle Res Cell Motil,2019,40(2):185-196.[20]Belo VA,Guimaraes DA,Castro MM.Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension[J].J Vasc Res,2015,52(4):221-231.

相似文献/References:

[1]冯 登,程 鹏,王 毅,等.miRNA在动脉粥样硬化中调控血管平滑肌细胞的研究进展[J].医学信息,2023,36(06):176.[doi:10.3969/j.issn.1006-1959.2023.06.040]
 FENG Deng,CHENG Peng,WANG Yi,et al.Research Progress of miRNA Regulating Vascular Smooth Muscle Cells in Atherosclerosis[J].Medical Information,2023,36(01):176.[doi:10.3969/j.issn.1006-1959.2023.06.040]

更新日期/Last Update: 1900-01-01